Undervalued Stocks: Pfizer and 4 Other Companies Trading Below Their 5 Year Average PE
Synopsis: Several Indian stocks like IRB Infrastructure, Pfizer Ltd, Jyoti CNC, HBL Engineering, and Anant Raj with market caps in the range of Rs. 20,000–24,700 cr are trading P/Es 28–61 vs 32–84 stock PEs, suggesting potential undervaluation. Small-cap stocks trading below their five-year P/E indicate potential undervaluation relative to historical norms, offering investors an opportunity […] The post Undervalued Stocks: Pfizer and 4 Other Companies Trading Below Their 5 Year Average PE appeared first on Trade Brains.
Synopsis: Several Indian stocks like IRB Infrastructure, Pfizer Ltd, Jyoti CNC, HBL Engineering, and Anant Raj with market caps in the range of Rs. 20,000–24,700 cr are trading P/Es 28–61 vs 32–84 stock PEs, suggesting potential undervaluation.
Small-cap stocks trading below their five-year P/E indicate potential undervaluation relative to historical norms, offering investors an opportunity to identify companies that may deliver long-term growth at attractive valuations.
Stocks across sectors like infrastructure, pharmaceuticals, industrial manufacturing, and engineering technology are currently below their five-year P/E, indicating relatively lower valuations compared to their historical stock PEs.
IRB Infrastructure Developers Ltd
An Indian company specializing in road and highway construction under Build‑Operate‑Transfer (BOT) and Hybrid Annuity Models. It develops and manages toll roads across India and is a mid‑cap stock, often influenced by project awards and toll revenue performance.
With a market capitalisation of Rs. 23,956 cr, the shares of IRB Infrastructure Developers Ltd closed at Rs. 39.67 per share, down from its previous close of Rs. 40.14 per share. The stock’s current P/E of 27.6 is below its 5-year average of 32.4, suggesting it may be undervalued relative to its historical valuation.
Pfizer Ltd
The Indian arm of the global pharma giant Pfizer, engaged in manufacturing and marketing drugs in vaccines, anti-infectives, and specialty medicines. It is a large‑cap stock with a steady earnings history, supported by new product launches and collaborations in India.
With a market capitalisation of Rs. 21,023 cr, the shares of Pfizer Ltd closed at Rs. 4,595.60 per share, down from its previous close of Rs. 4,723.30 per share. The stock P/E of 31.4 is below the five-year stock PE of 35.9, suggesting it may be undervalued relative to its historical valuation.
Jyoti CNC Automation Ltd
A leading Indian CNC machine manufacturer serving aerospace, defense, and general engineering sectors. The company has shown strong growth since its IPO, with solid revenue expansion and plans to increase production capacity.
With a market capitalisation of Rs. 18,202 cr, the shares of Jyoti CNC Automation Ltd closed at Rs. 800.40 per share, down from its previous close of Rs. 832.50 per share. The stock P/E of 61.5 is below the five-year stock PE of 84.5, suggesting it may be undervalued relative to its historical valuation.
HBL Engineering Ltd
An industrial technology firm known for batteries (lead, nickel‑cadmium, defense, and aviation) and electronics for railways and safety systems. It has a global market share in industrial batteries and benefits from contracts like railway signaling and safety systems.
With a market capitalisation of Rs. 19,554 cr, the shares of HBL Engineering Ltd closed at Rs. 705.45 per share, down from its previous close of Rs. 726.25 per share. The stock P/E of 35.5 is below the five-year stock PE of 46.3, suggesting it may be undervalued relative to its historical valuation.
Anant Raj Ltd
A Delhi-NCR-based real estate and infrastructure developer with projects in residential, commercial, and IT parks. It is expanding into data centers and digital infrastructure, with growth tied to property deliveries and strategic investments.
With a market capitalisation of Rs. 18,053 cr, the shares of Anant Raj Ltd closed at Rs. 501.65 per share, down from its previous close of Rs. 537.40 per share. The stock P/E of 41.5 is below the five-year stock PE of 45.9, suggesting it may be undervalued relative to its historical valuation.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Undervalued Stocks: Pfizer and 4 Other Companies Trading Below Their 5 Year Average PE appeared first on Trade Brains.
What's Your Reaction?

